LINC00893 inhibits the progression of prostate cancer through miR-3173-5p/SOCS3/JAK2/STAT3 pathway

BACKGROUND: Prostate cancer (PCa) is one of the most common malignant tumors in the male urinary system. In recent years, the morbidity and mortality of PCa have been increasing due to the limited effects of existing treatment strategies. Long non-coding RNA (lncRNA) LINC00893 was reported to inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chuigong, Fan, Yu, Zhang, Yu, Liu, Lupeng, Guo, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275192/
https://www.ncbi.nlm.nih.gov/pubmed/35818076
http://dx.doi.org/10.1186/s12935-022-02637-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275192/
https://www.ncbi.nlm.nih.gov/pubmed/35818076
http://dx.doi.org/10.1186/s12935-022-02637-4

Ejemplares similares